Aleafia Health logo
AH logo

Aleafia HealthTSX:AH Stock Report

Market Cap CA$8.1m
Share Price
n/a
1Y-69.2%
7D0%
Portfolio Value
View

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

AH Stock Overview

Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. More details

AH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Aleafia Health Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Aleafia Health
Historical stock prices
Current Share PriceCA$0.02
52 Week HighCA$0.09
52 Week LowCA$0.015
Beta1.73
1 Month Change0%
3 Month Change-33.33%
1 Year Change-69.23%
3 Year Change-96.08%
5 Year Change-98.04%
Change since IPO-97.94%

Recent News & Updates

Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)

Apr 19
Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)

Recent updates

Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)

Apr 19
Fewer Investors Than Expected Jumping On Aleafia Health Inc. (TSE:AH)

Why Aleafia Health Inc. (TSE:AH) Could Be Worth Watching

Jan 04
Why Aleafia Health Inc. (TSE:AH) Could Be Worth Watching

CA$0.29: That's What Analysts Think Aleafia Health Inc. (TSE:AH) Is Worth After Its Latest Results

Feb 17
CA$0.29: That's What Analysts Think Aleafia Health Inc. (TSE:AH) Is Worth After Its Latest Results

Analysts Are Betting On Aleafia Health Inc. (TSE:AH) With A Big Upgrade This Week

Feb 16
Analysts Are Betting On Aleafia Health Inc. (TSE:AH) With A Big Upgrade This Week

Here's Why Aleafia Health (TSE:AH) Can Afford Some Debt

Nov 10
Here's Why Aleafia Health (TSE:AH) Can Afford Some Debt

Analysts Expect Aleafia Health Inc. (TSE:AH) To Breakeven Soon

Feb 26
Analysts Expect Aleafia Health Inc. (TSE:AH) To Breakeven Soon

Introducing Aleafia Health (TSE:AH), A Stock That Climbed 29% In The Last Year

Jan 22
Introducing Aleafia Health (TSE:AH), A Stock That Climbed 29% In The Last Year

Would Aleafia Health (TSE:AH) Be Better Off With Less Debt?

Dec 18
Would Aleafia Health (TSE:AH) Be Better Off With Less Debt?

Shareholder Returns

AHCA PharmaceuticalsCA Market
7D0%-2.2%-1.0%
1Y-69.2%-49.7%14.4%

Return vs Industry: AH underperformed the Canadian Pharmaceuticals industry which returned -45.6% over the past year.

Return vs Market: AH underperformed the Canadian Market which returned 3% over the past year.

Price Volatility

Is AH's price volatile compared to industry and market?
AH volatility
AH Average Weekly Movement29.6%
Pharmaceuticals Industry Average Movement12.0%
Market Average Movement8.5%
10% most volatile stocks in CA Market18.1%
10% least volatile stocks in CA Market3.0%

Stable Share Price: AH's share price has been volatile over the past 3 months.

Volatility Over Time: AH's weekly volatility has increased from 18% to 30% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a158Tricia Symmeswww.aleafiahealth.com

Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. The company owns and operates a virtual network of medical cannabis clinics staffed through physicians and nurse practitioners. Its product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, pre-roll, milled, and vape cartridges; bath bombs and soft gels; hang dried, hand trimmed, long cured, and small batch dried flower; and concentrates.

Aleafia Health Inc. Fundamentals Summary

How do Aleafia Health's earnings and revenue compare to its market cap?
AH fundamental statistics
Market capCA$8.07m
Earnings (TTM)-CA$34.61m
Revenue (TTM)CA$42.85m

0.2x

P/S Ratio

-0.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AH income statement (TTM)
RevenueCA$42.85m
Cost of RevenueCA$36.85m
Gross ProfitCA$6.00m
Other ExpensesCA$40.61m
Earnings-CA$34.61m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.086
Gross Margin14.00%
Net Profit Margin-80.77%
Debt/Equity Ratio-499.1%

How did AH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/09/03 09:15
End of Day Share Price 2023/07/25 00:00
Earnings2023/03/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Aleafia Health Inc. is covered by 6 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nikolaas FaesBryan Garnier & Co
Pablo ZuanicCantor Fitzgerald & Co.
Graeme KreindlerEight Capital